Industry RFA

GSK Discovery Fast Track Challenge

The Discovery Fast Track Challenge is a challenge that recognizes and rewards innovative concepts, discoveries, and research by investigators at U.S. and Canadian research institutions, colleges, and universities. Winning investigators will collaborate with a team of GSK scientists to put their innovative research concept on an accelerated drug discovery path.

Johnson & Johnson Innovation Centers

The Johnson & Johnson Innovation Centers catalyze, support, and invest in highly differentiated early-stage innovations. The Centers bring together resources from across the company to meet the needs of entrepreneurs and scientists developing important medical device and diagnostic technologies, consumer health care products, and pharmaceuticals.

Lilly Open Innovation Drug Discovery

The Lilly Open Innovation Drug Discovery platform provides access to internal screening assays for external investigators as an in-kind contribution to their research.

Pfizer Centers for Therapeutic Innovation

The Pfizer Centers for Therapeutic Innovation partner with academic medical centers and disease foundations to translate research ideas into clinical applications, offering funding and resources to principal investigators and postdocs at academic medical centers to continue development and research on a promising therapeutic or hypothesis. Throughout the year, CTI issues calls for proposals to academic medical centers.

AstraZeneca Open Innovation

The AstraZeneca Open Innovation platform provides an open, collaborative approach to link our expertise, unique research tools, optimized molecules, technologies and challenges with your research capabilities and interests.  Working with AstraZeneca means access to optimized compounds, compound libraries, technologies, services and know-how, as well as the possibility of joint publications in high-profile journals. Most importantly, it brings the opportunity to see your ideas develop into treatments for patients who need them.